...
首页> 外文期刊>Radiation oncology >Feasibility of ipsilateral lower neck sparing irradiation for unilateral or bilateral neck node-negative nasopharyngeal carcinoma: systemic review and meta-analysis of 2, 521 patients
【24h】

Feasibility of ipsilateral lower neck sparing irradiation for unilateral or bilateral neck node-negative nasopharyngeal carcinoma: systemic review and meta-analysis of 2, 521 patients

机译:同侧下颈保留放射治疗单侧或双侧颈淋巴结阴性鼻咽癌的可行性:2,521例患者的系统评价和荟萃分析

获取原文
           

摘要

To compare the efficacy of ipsilateral lower neck sparing irradiation (ILNSI) versus ipsilateral lower neck prophylactic irradiation (ILNPI) for unilateral or bilateral neck node-negative nasopharyngeal cancer (NPC). A comprehensive literature search of PubMed, EMBASE, the Cochrane Library and other public databases was conducted in October, 2017. The outcomes were 3-year overall/regional recurrence-free/disease-free/distant metastasis-free survival (OS/RRFS/DFS/DMFS) and ipsilateral lower neck (ILN) recurrence. We performed subgroup analysis of ILNSI versus ILNPI for different radiotherapy techniques. Sensitivity analysis was performed to examine the stability of the results. Nine head-to-head comparative studies (2, 521 patients) were included in the meta-analysis. For the comparison of ILNSI versus ILNPI, there was no significant difference in 3-year OS (HR?=?1.16, 95% confidence interval [CI]?=?0.85–1.58, P?=?0.36), RRFS (HR?=?1.37, 95% CI?=?0.76–2.47, P?=?0.30), DFS (HR?=?1.08, 95% CI?=?0.80–1.44, P?=?0.62) and DMFS (HR?=?1.00, 95% CI?=?0.69–1.44, P?=?0.99). ILNSI and ILNPI also led to equivalent ILN recurrence rates (OR?=?0.98, 95% CI?=?0.47–2.03, P?=?0.96). No significant heterogeneity was observed for any outcome. Subgroup analysis confirmed no significant differences between ILNSI and ILNPI for any outcome, regardless of radiotherapy technique. Sensitivity analysis indicated all outcomes were highly stable in favor of the original conclusions. ILNSI provided equivalent survival outcomes and regional control compared to ILNPI; ILNSI represents an appropriate alternative strategy for patients with unilateral or bilateral neck node-negative NPC.
机译:为了比较同侧下颈保留照射(ILNSI)与同侧下颈预防性照射(ILNPI)对单侧或双侧颈淋巴结阴性鼻咽癌(NPC)的疗效。 2017年10月对PubMed,EMBASE,Cochrane图书馆和其他公共数据库进行了全面的文献检索。结果为3年总体/区域无复发/无疾病/无远处转移生存(OS / RRFS / DFS / DMFS)和同侧下颈(ILN)复发。我们针对不同的放射治疗技术对ILNSI和ILNPI进行了亚组分析。进行敏感性分析以检查结果的稳定性。荟萃分析包括九项头对头比较研究(2 521例患者)。对于ILNSI与ILNPI的比较,3年OS(HR≥1.16,95%置信区间[CI]≥0.85-1.58,P≥0.36),RRFS(HR≥3)无显着差异。 =?1.37,95%CI?=?0.76-2.47,P?=?0.30),DFS(HR?=?1.08,95%CI?=?0.80-1.44,P?=?0.62)和DMFS(HR? =?1.00,95%CI?=?0.69-1.44,P?=?0.99)。 ILNSI和ILNPI也导致同等的ILN复发率(OR = 0.98,95%CI = 0.47–2.03,P = 0.96)。没有观察到任何结果的显着异质性。亚组分析证实,无论放疗技术如何,ILNSI和ILNPI在任何结局方面均无显着差异。敏感性分析表明,所有结果均高度稳定,支持原始结论。与ILNPI相比,ILNSI提供了同等的生存结果和区域控制; ILNSI代表单侧或双侧颈淋巴结阴性NPC患者的适当替代策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号